Subscribe To
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced the pricing of an underwritten public offering of 7,250,000 shares of its common stock at a public […] The post Cabaletta Bio Announces Pricing of Public Offering of Common Stock appeared first on ForexTV...
Read More
Posted: May 18 2023, 02:16
Author Name: forextv
Views: 111492